Diazoxide protects myocardial mitochondria, metabolism, and function during cardiac surgery: A double-blind randomized feasibility study of diazoxide-supplemented cardioplegia

Journal of Thoracic and Cardiovascular Surgery

Volumn 137, Issue 4, 2009, Pages

  Deja, Marek A ^a   Malinowski, Marcin ^a   Gołba, Krzysztof S ^a   Kajor, Maciej ^a   Lebda Wyborny, Tomasz ^a   Hudziak, Damian ^a   Domaradzki, Wojciech ^a   Szurlej, Dariusz ^a   Bończyk, Andrzej ^a   Biernat, Jolanta ^a   Woś, Stanisław ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART SURGERY; HEMODYNAMICS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT;

EID: 62849097009     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.08.068     Document Type: Article

References (30)

1. McCully J.D., and Levitsky S. Mitochondrial ATP-sensitive potassium channels in surgical cardioprotection. Arch Biochem Biophys 420 (2003) 237-245
2. Lesnefsky E.J., Moghaddas S., Tandler B., Kerner J., and Hoppel C.L. Mitochondrial dysfunction in cardiac disease: ischemia-reperfusion, aging, and heart failure. J Mol Cell Cardiol 33 (2001) 1065-1089
3. Hoppel C., Kerner J., Turkaly P., and Tandler B. Rat liver mitochondrial contact sites and carnitine palmitoyltransferase-I. Arch Biochem Biophys 392 (2001) 321-325
4. Juhaszova M., Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113 (2004) 1535-1549
5. Akao M., O'Rourke B., Kusuoka H., Teshima Y., Jones S.P., and Marban E. Differential actions of cardioprotective agents on the mitochondrial death pathway. Circ Res 92 (2003) 195-202
6. Hanley P.J., and Daut J. K(ATP) channels and preconditioning: a re-examination of the role of mitochondrial K(ATP) channels and an overview of alternative mechanisms. J Mol Cell Cardiol 39 (2005) 17-50
7. Al-Dadah A.S., Voeller R.K., Schuessler R.B., Damiano Jr. R.J., and Lawton J.S. Maintenance of myocyte volume homeostasis during stress by diazoxide is cardioprotective. Ann Thorac Surg 84 (2007) 857-862
8. Deja M.A., Golba K.S., Malinowski M., Widenka K., Biernat J., Szurlej D., et al. Diazoxide provides maximal KATP channels independent protection if present throughout hypoxia. Ann Thorac Surg 81 (2006) 1408-1416
9. Deja M.A., Golba K.S., Kolowca M., Widenka K., Biernat J., and Wos S. Diazoxide provides protection to human myocardium in vitro that is concentration dependent. Ann Thorac Surg 77 (2004) 226-232
10. Wang X., Wei M., Kuukasjarvi P., Laurikka J., Jarvinen O., Rinne T., et al. Novel pharmacological preconditioning with diazoxide attenuates myocardial stunning in coronary artery bypass grafting. Eur J Cardiothorac Surg 24 (2003) 967-973
11. Ozcan C., Holmuhamedov E.L., Jahangir A., and Terzic A. Diazoxide protects mitochondria from anoxic injury: implications for myopreservation. J Thorac Cardiovasc Surg 121 (2001) 298-306
12. McCully J.D., Wakiyama H., Cowan D.B., Federman M., Parker R.A., and Levitsky S. Diazoxide amelioration of myocardial injury and mitochondrial damage during cardiac surgery. Ann Thorac Surg 74 (2002) 2138-2145
13. Lim K.H., Javadov S.A., Das M., Clarke S.J., Suleiman M.S., and Halestrap A.P. The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration. J Physiol 545 suppl (2002) 961-974
14. Wakahara N., Katoh H., Yaguchi Y., Uehara A., Satoh H., Terada H., et al. Difference in the cardioprotective mechanisms between ischemic preconditioning and pharmacological preconditioning by diazoxide in rat hearts. Circ J 68 (2004) 156-162
15. Garlid K.D., Paucek P., Yarov-Yarovoy V., Murray H.N., Darbenzio R.B., D'Alonzo A.J., et al. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res 81 (1997) 1072-1082
16. Toyoda Y., Levitsky S., and McCully J.D. Opening of mitochondrial ATP-sensitive potassium channels enhances cardioplegic protection. Ann Thorac Surg 71 (2001) 1281-1288
17. Ghosh S., Standen N.B., and Galinianes M. Failure to precondition pathological human myocardium. J Am Coll Cardiol 37 (2001) 711-718
18. Cohen G., Feder-Elituv R., Iazetta J., Bunting P., Mallidi H., Bozinovski J., et al. Phase 2 studies of adenosine cardioplegia. Circulation 98 suppl (1998) II225-II233
19. Ogilvie R.I., Nadeau J.H., and Sitar D.S. Diazoxide concentration-response relation in hypertension. Hypertension 4 (1982) 167-173
20. Olsson R.A., and Gregg D.E. Metabolic responses during myocardial reactive hyperemia in the unanesthetized dog. Am J Physiol 208 (1965) 231-236
21. Levitsky S., and McCully J.D. Myocardial protection. In: Sellke F.W., del Nido P.L., and Swanson S.J. (Eds). Sabiston & Spencer surgery of the chest Volume 1. 7th ed (2005), Elsevier Saunders, Amsterdam 1081-1102
22. Lawton J.S., Hsia P.W., McClain L.C., Maier G.W., and Damiano Jr. R.J. Myocardial oxygen consumption in the rabbit heart after ischemia: hyperpolarized arrest with pinacidil versus depolarized hyperkalemic arrest. Circulation 96 suppl (1997) II52
23. Pietersen H.G., Langenberg C.J., Geskes G., Kester A., de Lange S., Van der Vusse G.J., et al. Myocardial substrate uptake and oxidation during and after routine cardiac surgery. J Thorac Cardiovasc Surg 118 (1999) 71-80
24. Reich D.L., Moskowitz D.M., and Kaplan J.A. Hemodynamic Monitoring. In: Kaplan J.A., Reich D.L., and Konstadt S.N. (Eds). Cardiac anesthesia. 4th ed (1999), Saunders, Amsterdam 321-358
25. Krauss X.H., Verdouw P.D., Hughenholtz P.G., and Nauta J. On-line monitoring of mixed venous oxygen saturation after cardiothoracic surgery. Thorax 30 (1975) 636-643
26. Watanabe M., Egi K., Hasegawa S., Tanaka H., Ohshima H., Sakamoto T., et al. Significance of serum atrial and brain natriuretic peptide release after coronary artery bypass grafting. Surg Today 33 (2003) 671-673
27. Nagaya N., Nishikimi T., Goto Y., Miyao Y., Kobayashi Y., Morii I., et al. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction. Am Heart J 135 (1998) 21-28
28. Julier K., da S.R., Garcia C., Bestmann L., Frascarolo P., Zollinger A., et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology 98 (2003) 1315-1327
29. Engler R.L., and Yellon D.M. Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease. Time for reconsideration. Circulation 94 (1996) 2297-2301
30. McCully J.D., Toyoda Y., Wakiyama H., Rousou A.J., Parker R.A., and Levitsky S. Age- and gender-related differences in ischemia/reperfusion injury and cardioprotection: effects of diazoxide. Ann Thorac Surg 82 (2006) 117-123